The Coca-Cola Company and Pernod Ricard Announce Plans to Debut Absolut Vodka & Sprite Ready-To-Drink Cocktail
The Coca-Cola Company and Pernod Ricard today announced a global relationship to debut Absolut Vodka & Sprite as a ready-to-drink pre-mixed cocktail in 2024.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231016141983/en/
Absolut & Sprite will be made with Absolut, the international premium vodka, and Sprite, the world’s most popular lemon-lime sparkling soft drink. The pre-mixed cocktail will be available in versions with Sprite and Sprite Zero Sugar, with the initial launch planned for select European countries in early 2024, including the United Kingdom, the Netherlands, Spain and Germany.
“We keep consumers at the center of everything we do as we continue to develop our portfolio as a total beverage company,” said James Quincey, Chairman and CEO of The Coca-Cola Company. “We are expanding in the alcohol ready-to-drink space, including products that use select brands from our core portfolio. We are excited about our new relationship with Pernod Ricard and look forward to the introduction of Absolut & Sprite.”
“This very promising and pioneering project brings together two leading companies who are committed to offering their consumers new experiences around premium products,” said Alexandre Ricard, CEO of Pernod Ricard, a worldwide leader in the spirits and wine industry.
Vodka is one of the most popular bases for alcohol ready-to-drink products, and lemon-lime soft drinks are one of the most popular mixers in pre-mixed cocktails.
“Sprite is a wonderful pairing for Absolut, and I’m convinced that our joining forces will bring the whole alcohol RTD category to the next level,” Ricard said.
Absolut & Sprite ready-to-drink packaging will feature two of the world’s most recognizable global trademarks. Absolut was established in 1879 in Sweden. Since then, it has become a world-renowned premium vodka brand, crafted using the finest Swedish winter wheat. Sprite was established in 1959 in Germany and has grown to be one of the biggest brands in The Coca-Cola Company’s global portfolio.
Cans will include clear responsibility symbols stating that the drink is to be enjoyed only by consumers of legal drinking age. Absolut & Sprite ready-to-drink will adhere to responsible marketing practices.
The global benchmark for alcohol beverage volume (ABV) is 5% but will vary depending on the market.
About The Coca-Cola Company
The Coca-Cola Company (NYSE: KO) is a total beverage company with products sold in more than 200 countries and territories. Our company’s purpose is to refresh the world and make a difference. We sell multiple billion-dollar brands across several beverage categories worldwide. Our portfolio of sparkling soft drink brands includes Coca-Cola, Sprite and Fanta. Our hydration, sports, coffee and tea brands include Dasani, smartwater, vitaminwater, Topo Chico, BODYARMOR, Powerade, Costa, Georgia, Gold Peak and Ayataka. Our nutrition, juice, dairy and plant-based beverage brands include Minute Maid, Simply, innocent, Del Valle, fairlife and AdeS. We’re constantly transforming our portfolio, from reducing sugar in our drinks to bringing innovative new products to market. We seek to positively impact people’s lives, communities and the planet through water replenishment, packaging recycling, sustainable sourcing practices and carbon emissions reductions across our value chain. Together with our bottling partners, we employ more than 700,000 people, helping bring economic opportunity to local communities worldwide. Learn more at www.coca-colacompany.com and follow us on Instagram, Facebook and LinkedIn.
About Pernod Ricard
Pernod Ricard is a worldwide leader in the spirits and wine industry, blending traditional craftsmanship, state-of-the-art brand development, and global distribution technologies. Our prestigious portfolio of premium to luxury brands includes Absolut Vodka, Ricard pastis, Ballantine’s, Chivas Regal, Royal Salute, and The Glenlivet Scotch whiskies, Jameson Irish whiskey, Martell cognac, Havana Club rum, Beefeater gin, Malibu liqueur and Mumm and Perrier-Jouët champagnes. Our mission is to ensure the long-term growth of our brands with full respect for people and the environment, while empowering our employees around the world to be ambassadors of our purposeful, inclusive and responsible culture of authentic conviviality. Pernod Ricard’s consolidated sales amounted to € 12,137 million in fiscal year FY23. Pernod Ricard is listed on Euronext (Ticker: RI; ISIN Code:FR0000120693) and is part of the CAC 40 and Eurostoxx 50 indices.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231016141983/en/
Contact information
The Coca-Cola Company:
Investors and Analysts: Robin Halpern, koinvestorrelations@coca-cola.com
Media: Scott Leith, sleith@coca-cola.com
Pernod Ricard/Absolut:
Media: Emmanuel Vouin, Emmanuel.vouin@pernod-ricard.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Sustainable Forestry Coalition Welcomes New Member, Suzano6.12.2023 11:37:00 CET | Press release
In September a group of leading global sustainable forestry companies launched the International Sustainable Forestry Coalition (ISFC), to enable the sector to positively contribute to global policy processes focused on the transition from a fossil-based economy to a circular bioeconomy. Today the ISFC is delighted to announce that Suzano, one of the world’s major forestry sector companies, has become a member. Suzano, headquartered in Brazil, is a globally respected forestry sector leader. With almost a hundred years in operation, the company manages extensive sustainable timber plantation estates and forest conservation areas, and creates a vast range of fibre-based products. One out of every three tissue products used in the world today will have come from Suzano’s operations. Convening Chair of the ISFC Dr. David Brand said, “With the inclusion of Suzano in the ISFC, the group represents more than 12.6 million hectares (31 million acres) of forests for conservation and production i
Forrester: European Retail Sales To Reach €2.7 Trillion By 20286.12.2023 11:00:00 CET | Press release
Forrester (Nasdaq: FORR) forecasts that total retail sales of Europe-5 countries (France, Germany, Italy, Spain, and the UK) will increase from €2.3 trillion in 2023 to reach €2.7 trillion in 2028 at a 2.9% compound annual growth rate (CAGR). Forrester’s recently released report, Europe-5 Online Retail Forecast, 2023 To 2028, estimates total retail sales, online retail sales, and online retail penetration across 22 product categories, including fashion, homeware, food and drink, consumer electronics, and media, for each of the Europe-5 economies. Germany holds the largest share of the retail market among these five countries, followed (in order) by the UK and France. In 2022, offline retail growth outpaced online retail growth for the first time as more consumers shopped in stores, and this momentum continued into 2023, but the fundamental growth drivers of online retail such as greater product selection, round-the-clock availability, and competitive pricing remain strong. As a result,
Kaneka Acquires Japan Medical Device Technology6.12.2023 10:40:00 CET | Press release
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka)(TOKYO:4118) has acquired all shares of Japan Medical Device Technology Co., Ltd. (Headquarters: Kamimashiki-gun, Kumamoto; President: Shuzo Yamashita) (hereinafter JMDT), a developer and manufacturer of medical devices, on November 30, 2023, and made it a wholly owned subsidiary. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231206372197/en/ Stent before expansion (Photo: Business Wire) Kaneka manufactures and sells endovascular catheters, which are devices used in the treatment of cardiac, peripheral vascular, and cerebrovascular diseases. In particular, stenting*1 for the treatment of coronary artery diseases such as atherosclerosis has a market worth 30 billion yen in Japan, and Kaneka is aiming to expand its business in this area. JMDT has high technological capabilities in the research and development of coronary stents and is one of the lead
CommBox launches Era AI to enable customer service to be intelligently automated and CX costs to be cut by 40%6.12.2023 10:00:00 CET | Press release
Today CommBox, the pioneer in AI-powered customer communications, is launching its new generative AI solution. Designed for medium to large businesses across a range of industries including healthcare, banking, retail, telecommunications and insurance, Era AI is based on a winning combination of both proprietary technology developed by CommBox and commercial large language models. Era AI’s functionality scans enterprise knowledge sources and, in just seconds, provides customers with accurate, highly personalised information through the digital messaging channel of their choice. Era AI delivers customer service automation, reduces costs for organisations, and dramatically increases the speed and accuracy of enquiry handling. It does this all while increasing customer satisfaction, with CommBox customers seeing a 92% customer satisfaction rate on average. Central to this is Era AI’s ability to analyse a brand’s entire resource base, such as support articles, help and knowledge centres, a
New Post Hoc Phase 3 Data Analysis Shows AJOVY ® (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity6.12.2023 08:00:00 CET | Press release
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announces that a post hoc analysis4 of two phase 3 clinical studies presented today at the European Headache Congress has shown the effectiveness of the migraine prevention treatment AJOVY®(fremanezumab) in reducing migraine attacks in patients with migraine and co-morbid obesity. Migraine and obesity are both associated with high levels of disability3 and both conditions are more prevalent amongst females5,6. It is estimated that 59% of people in Europe are either overweight or obese, with almost a quarter (23%) of adults living with obesity5. A higher body mass index (BMI) is frequently associated with increased migraine prevalence and severity, and an increased number of adverse effects3. As such, assessing the efficacy and safety of migraine preventative treatment in patients with obesity can help guide migraine management and treatment decisions. The post hoc analysis of the HALO-LTS1 and FOCUS2 phase 3 studies compared the